A-Mansia Biotech
Louvain-la-neuve
About A-Mansia Biotech
A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering the intestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $19.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2018)
- Website: a-mansia.com
Industries & Categories
Biopharma, Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/a-mansia-biotech-70837 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.